AAPL $264.58 +1.24% MSFT $397.23 -0.93% GOOGL $314.98 -1.35% AMZN $210.11 +0.47% NVDA $189.82 +1.43% TSLA $411.82 -0.83% META $655.66 -1.32% JPM $310.79 -1.32% V $320.95 +0.00% WMT $122.99 +0.95% AAPL $264.58 +1.24% MSFT $397.23 -0.93% GOOGL $314.98 -1.35% AMZN $210.11 +0.47% NVDA $189.82 +1.43% TSLA $411.82 -0.83% META $655.66 -1.32% JPM $310.79 -1.32% V $320.95 +0.00% WMT $122.99 +0.95%

NASDAQ: GRAL

GRAIL, Inc.

Healthcare • Medical - Diagnostics & Research • www.grail.com

$50.21 $-51.32 (-50.55%)

As of Feb 21, 10:47 PM UTC

Key Statistics

Market Cap $3.32B
P/E Ratio -8.44
Dividend Yield 0.00%
Volume 15,408,586
Avg Volume 1,122,233
52-Week High N/A
52-Week Low N/A

About GRAIL, Inc.

GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.

Analyst Ratings

View All →
N/A Based on 0 analysts
Avg Price Target $92.50 (+84.2% upside)

GRAL News

View All →

FEATURED BY